Big drug companies have little incentive to develop new antibiotics despite huge concerns about resistance to the drugs, according to a group of leading pharmacists.
The Royal Pharmaceutical Society (RPS) said the prospect of creating new drugs was "low due to the poor return on investment they provide".
The RPS said in its latest report that more must be done to support the discovery of new antibiotics.
It also called for the public to become more educated on the use of the medicines and better management of the drugs by healthcare workers.
More top news
Parliamentary inquiry into the retailer's role in BHS's failure is a damning indictment of an entrepreneur who was trumpeted over the years.
Damning parliamentary inquiry accuses the retail magnate of seeking to blame anyone but himself for the collapse of BHS.
The cyclist said the victory was as sweet as his first win as he became the first Briton to win the race three times.